Charles River Laboratories
CRL
CRL
624 hedge funds and large institutions have $10.3B invested in Charles River Laboratories in 2024 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 203 increasing their positions, 272 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 272
32% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 97
38% less call options, than puts
Call options by funds: $59M | Put options by funds: $94.8M
Holders
624
Holding in Top 10
6
Calls
$59M
Puts
$94.8M
Top Buyers
| 1 | +$736M | |
| 2 | +$198M | |
| 3 | +$100M | |
| 4 |
IC
Impactive Capital
New York City,
New York
|
+$74.1M |
| 5 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$59.2M |
Top Sellers
| 1 | -$167M | |
| 2 | -$102M | |
| 3 | -$94.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$92.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$63.7M |